Search

UK-based MHRA-approved pharmaceutical wholesaler and exporter for branded medicines, generics and cold-chain supply.

Import, export, named-patient supply, comparator sourcing, cold-chain, warehousing and portfolio management services.

Branded, generic, cold-chain and hospital medicines. Contact Logan Pharmaceuticals for product availability and supply enquiries.

A Glasgow-based, family-built pharmaceutical wholesaler focused on integrity, quality and dependable regulated supply.

Quality management, GDP-compliant workflows, cold-chain control and regulatory readiness across Logan Pharmaceuticals operations.

Logan Pharmaceuticals articles on pharmaceutical distribution, supply chains, personal health, digital pharmacy and market trends.

Contact Logan Pharmaceuticals in Glasgow for pharmaceutical wholesale, export, storage, supply and quality enquiries.

Enquiry-led support for named-patient medicine supply, with each request reviewed against applicable regulatory, documentation and availability requirements.

Pharmaceutical sourcing and cross-border supply, with attention to the requirements of the product and destination market.

Sourcing support for reference listed drugs and comparator medicines, shaped around the market, batch, documentation and handling requirements of each enquiry.

Wholesale pharmaceutical supply for pharmacies, hospitals and wholesalers. Contact the team for current availability and delivery options.

Support for pharmaceutical brands considering their product portfolio and supply requirements in UK and international markets.

Pharmaceutical storage and third-party logistics enquiries, with arrangements shaped around the product and its handling requirements.

Cold-chain support for temperature-sensitive pharmaceuticals, including medicines beyond biologics. Handling arrangements depend on the product and its storage requirements.

The treatment landscape for RAS-driven cancers is entering a new phase. RAS proteins have long been recognised as major drivers of tumour growth, but directly targeting the RA...

A narrow stretch of water between Iran and Oman has become one of the most consequential variables in global medicines logistics. Since late February 2026, restricted transit...

The MHRA's London Region I AI Regulatory Sandbox points to a more evidence-led future for healthcare technology and pharmaceutical supply-chain governance.

The weight-management landscape is changing faster than at almost any point in modern pharmacotherapy. For years, effective GLP-1 treatment meant one thing: a weekly injection...

MHRA's July 2026 approval of lower-carbon beclometasone inhalers shows how medicine innovation now joins clinical, regulatory and sustainability planning.

MHRA's July 2026 summer storage warning is a reminder that heat, handling and documentation matter across medicine supply chains.

A July 2026 update to the UK restricted medicines list shows why wholesalers need current export controls, stock discipline and GDP records.

DHSC's 2026 statutory scheme update resets branded medicines payment percentages. We summarise the market-access signals for suppliers.

The 2026 MHRA-NICE aligned pathway brings licensing and NICE appraisal milestones closer together. Here is what supply partners should prepare for.

Introduction The GLP-1 revolution obesity drugs era is here. These glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are no longer niche diabetes treatments but the corner...

Background - a steep Mounjaro price increase in the UK in 2025 As the Mounjaro price increase UK 2025 approaches, on 14 August 2025, the pharmaceutical manufacturer Eli Lilly...

Africa's pharmaceutical market is in the middle of a transformation. The sector is expected to grow from USD 27.43 billion in 2024 to USD 38.24 billion by 2033[1], and mobile...

If you're a wholesaler or pharmacy serving Africa, you know how important it is to stock antibiotics that your customers can trust - ones that are effective, affordable, and e...

In the rapidly evolving field of healthcare, obesity management has become a critical focus. GLP-1 (glucagon-like peptide-1) agonists, such as Mounjaro and Wegovy, are transfo...

Introduction Monkeypox, a rare viral disease, has garnered global attention due to its rising cases across various regions. Although it shares similarities with smallpox, monk...

The simmering tensions in the Red Sea and Bab al-Mandab Strait are sending ripples through one of the world's busiest shipping arteries, directly impacting the vital pharmaceu...

The pharmaceutical industry is constantly evolving, and one of the latest developments is the rise of biosimilars. While biosimilars are often compared to generic drugs, they...

The pharmaceutical wholesale industry has always been known for its complex supply chain, which involves the distribution of drugs from manufacturers to retailers. This indust...

What Is the Ozempic Face Phenomenon? If you've been following the news, you may have heard about the so-called Ozempic face. This refers to wrinkles and sagging skin that can...